Recently, the BARHL1/DDX31 super-enhancer was identified as an element that activates the GFI1B oncogene when fused to it by chromosomal deletion in subsets of Group 3 and Group 4 medulloblastomas [60]. Here, DDX31 is linked to medulloblastoma.